(CIDRAP News) Influenza vaccine doses intended for those at highest risk for serious complications from the flu made it into the arms of the right people, the Centers for Disease Control and Prevention (CDC) in Atlanta said yesterday.
(CIDRAP News) The new recommendation to vaccinate children between 6 and 23 months old could have been lost in the hubbub of the influenza vaccine shortage this season. Yet authorities are terming this year's vaccination rates a success story.
(CIDRAP News) In one of several reports on influenza vaccine last week, federal health officials reported that about a third of people who responded to a survey last winter thought that the vaccine caused flu.
(CIDRAP News) To keep influenza vaccine from going to waste, the government announced today that more people will be eligible to receive flu shots starting Jan 3 where supplies are adequate.
(CIDRAP News) Pushed by this year's influenza vaccine crisis, Congress recently approved $99 million to improve the nation's capacity to produce influenza vaccine, according to the Centers for Disease Control and Prevention (CDC).
(CIDRAP News) Federal health officials painted a rosy picture of the influenza vaccine supply today, saying most states have enough vaccine and the nation as a whole seems to have enough to meet the demand from groups who need the shots the most.
(CIDRAP News) When doctors in Maryland needed influenza vaccine for high-risk patients recently, they didn't send a request to a private distributor. They turned to Minnesota instead.
As part of efforts to improve the nation's long-term supply of influenza vaccine, the federal government is launching a clinical trial to help get a German-made vaccine licensed for regular use in the United States.
(CIDRAP News) If states have extra influenza vaccine left in the private sector after the demand from high-priority groups has been met, people in lower-priority groups should be allowed to get flu shots, federal health officials said yesterday.
(CIDRAP News) Freelance vaccinations and offers of bootleg vaccine are two unusual side effects of the US influenza vaccine shortage.
